News | September 30, 2023
Advent International announces the completion of the acquision of Suven Pharma
New Board of Directors and management team at Suven Pharma also appointed
New Board of Directors and management team at Suven Pharma also appointed
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
The company reported lifetime high EBIDTA of Rs. 250 crores
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Bourgoin early development hub broadens offerings for oral solid dose formulations
He was previously associated with renowned companies such as Granules India Ltd, Dr. Reddy’s Laboratories ltd & Aptar Group
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
_256_384.jpg)
The Indian companies that have been granted licences are Cipla, Sun Pharma, Laurus Labs, Divis Labs, Glenmark, Cadila, Torrent, Emcure, McLeods, SMS Pharmaceuticals, Strides, Biocon, Aurobindo Pharma, Hetero, Granules, Amneal, MSN, Arene Life Sciences and Viatris
Subscribe To Our Newsletter & Stay Updated
